Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +32.1% | +28.1% | 3 / 3 | +15.1% | -0.06 pp | +1.31 pp | +11.6% | 0.00 | 5.85 | 69,4 | +15,1% | 7,1 | +32,1% | 5.85 | 9.45 | −38,1% |
| Pts | 8 | 4 | 12 | 8 | 4 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 12.700 (close price on 2026-10-09)EPS (TTM): 2.170
Financial charts
1.Revenue & growth
VND bn69,4Q2/26
1.Revenue & growth
VND bn69,4Q2/26
2.Profit & growth
VND bn7,08Q2/26
3.Profit mix (Penman)
VND bn10,9Q2/26
4.Margins & cost structure
%24.9%Q2/26
5.Returns & cash cycle
% · days40.8%Q2/26
6.Earnings quality & cash
VND bn2,13Q2/26
7.Asset structure
VND bn126Q2/26
8.Funding & debt health
VND bn · times126Q2/26
9.Revenue backlog
VND bn0,10Q2/26
10.Valuation
times · %5,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.771Q2/26
Adjusted EPS growth, latest quarter
32.1%
Average adjusted EPS growth, 3 quarters
32.1%
averaged over 1 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26